These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 17637172)
1. Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-beta cyclodextrin. Wempe MF; Buchanan CM; Buchanan NL; Edgar KJ; Hanley GA; Ramsey MG; Skotty JS; Rice PJ J Pharm Pharmacol; 2007 Jun; 59(6):795-802. PubMed ID: 17637172 [TBL] [Abstract][Full Text] [Related]
2. The effect of tamoxifen on the pharmacokinetics of letrozole in female rats. Tao X; Brodie AM; Nnane IP Biopharm Drug Dispos; 2006 Oct; 27(7):335-44. PubMed ID: 16912967 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of raloxifene in male Wistar-Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrin. Wempe MF; Wacher VJ; Ruble KM; Ramsey MG; Edgar KJ; Buchanan NL; Buchanan CM Int J Pharm; 2008 Jan; 346(1-2):25-37. PubMed ID: 17644287 [TBL] [Abstract][Full Text] [Related]
4. Gender difference in letrozole pharmacokinetics in rats. Liu XD; Xie L; Zhong Y; Li CX Acta Pharmacol Sin; 2000 Aug; 21(8):680-4. PubMed ID: 11501174 [TBL] [Abstract][Full Text] [Related]
5. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen. Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-beta-cyclodextrin formulations. Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF Biomacromolecules; 2008 Jan; 9(1):305-13. PubMed ID: 18072746 [TBL] [Abstract][Full Text] [Related]
7. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole. Li L; Fang L; Xu X; Liu Y; Sun Y; He Z Biopharm Drug Dispos; 2010 Mar; 31(2-3):138-49. PubMed ID: 20140970 [TBL] [Abstract][Full Text] [Related]
8. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation. Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025 [TBL] [Abstract][Full Text] [Related]
9. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats. Wang L; Jiang X; Xu W; Li C Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the bioavailability of flurbiprofen and its beta-cyclodextrin inclusion complex in four different doses upon oral administration to rats. Muraoka A; Tokumura T; Machida Y Eur J Pharm Biopharm; 2004 Nov; 58(3):667-71. PubMed ID: 15451543 [TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
12. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits. Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678 [TBL] [Abstract][Full Text] [Related]
13. Complex of 9-nitro-camptothecin in hydroxypropyl-beta-cyclodextrin: in vitro and in vivo evaluation. Jiang Y; Sha X; Zhang W; Fang X Int J Pharm; 2010 Sep; 397(1-2):116-21. PubMed ID: 20637848 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations. Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849 [TBL] [Abstract][Full Text] [Related]
16. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin. Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-beta-cyclodextrin formulations. Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Malcolm MO; Ruble KM; Wacher VJ; Wempe MF J Pharm Sci; 2007 Mar; 96(3):644-60. PubMed ID: 17083091 [TBL] [Abstract][Full Text] [Related]
18. Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration. Lin HS; Chan SY; Low KS; Shoon ML; Ho PC J Pharm Sci; 2000 Feb; 89(2):260-7. PubMed ID: 10688755 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis. Dave N; Gudelsky GA; Desai PB Cancer Chemother Pharmacol; 2013 Aug; 72(2):349-57. PubMed ID: 23748921 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. Piette M; Evrard B; Frankenne F; Chiap P; Bertholet P; Castagne D; Foidart JM; Delattre L; Piel G Eur J Pharm Sci; 2006 Jun; 28(3):189-95. PubMed ID: 16520026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]